Form 4: Owens & Minor EVP, CEO Patient Direct, Perry A. Bernocchi, Sells Shares
SEC Form 4 Filing
Perry A. Bernocchi, EVP, CEO Patient Direct at Owens & Minor, Inc., sold a total of 24,094 shares of common stock on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 1, 2024, Perry A. Bernocchi, EVP, CEO Patient Direct at Owens & Minor, Inc., sold 3,890 shares of common stock at a price of $24.53 per share.
- Additionally, Bernocchi sold 20,204 shares of common stock at a weighted average price of $24.2654, with prices ranging from $23.870 to $24.800.
- These sales were executed under a Rule 10b5-1 trading plan adopted on August 11, 2023.
- Following these transactions, Bernocchi directly owns 170,497 shares of Owens & Minor common stock.
Sentiment
Score: 5
Explanation: The document simply reports stock sales by an executive, which is neutral in sentiment. The existence of a 10b5-1 plan suggests the sales were pre-planned.
Industry Context
Sales by company executives are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on current insider information.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/01/2024 | Date of stock sale transactions |
| 05/03/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.